Table 4.
Multivariate logistic analysis for MASLD Using HSI (>36) according to obese phenotypes in 252 RTRs 1.
Crude Model | Model 1 | Model 2 | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | |
HSI | |||||||||
MHNO | 1 | 1 | 1 | ||||||
MHO | 11.11 | 2.72–45.39 | 0.304 | 11.31 | 2.68–47.80 | 0.305 | 7.91 | 1.74–35.91 | 0.697 |
MANO | 3.13 | 1.05–9.75 | 0.058 | 2.61 | 0.86–7.88 | 0.027 | 2.74 | 0.88–8.52 | 0.056 |
MAO | 54.42 | 11.26–264.01 | 0.0002 | 66.34 | 12.69–346.75 | 0.0001 | 74.59 | 13.29–418.68 | 0.0001 |
Abbreviations: RTRs, renal transplant recipients; MASLD, metabolic-associated steatotic liver disease; HSI, hepatic steatosis index; OR, odds ratio; CI, confidence interval; MHNO, metabolically healthy nonobese; MHO, metabolically healthy obese; MANO, metabolically abnormal nonobese; MAO, metabolically abnormal obese. 1 Statistical analyses were conducted using logistic regression analysis. Model 1: adjustment for age and sex. Model 2: model 1 + adjustment for total energy intake, comorbidity, kidney transplant date, donor source, and immunosuppressant use.